Skip to main content

Molecular Diagnosis of Autoimmune Blistering Diseases

  • Protocol
  • First Online:
Molecular Dermatology

Part of the book series: Methods in Molecular Biology ((MIMB,volume 961))

Abstract

Autoimmune bullous diseases are the best-characterized autoimmune skin diseases. Molecular diagnosis of these diseases has become possible due to the identification of their target autoantigens over the past three decades. In this review, we summarize methodology for categorizing autoimmune bullous diseases by means of combinations of direct and indirect immunofluorescence techniques using normal human skin sections, rat bladder sections and COS7 cells transfected with desmocollins 1–3 encoded vectors, enzyme-linked immunosorbent assays and immunoblotting with normal human epidermal extracts, dermal extracts, purified proteins from cell cultures and recombinant proteins.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Lleo A, Invernizzi P, Gao B, Podda M, Gershwin ME (2010) Definition of human autoimmunity-autoantibodies versus autoimmune disease. Autoimmun Rev 9:A259–A266

    Article  PubMed  CAS  Google Scholar 

  2. Lin YS, Yeh TM, Lin CF, Wan SW, Chuang YC, Hsu TK, Liu HS, Liu CC, Anderson R, Lei HY (2011) Molecular mimicry between virus and host and its implications for dengue disease pathogenesis. Exp Biol Med (Maywood) 236:515–523

    Article  CAS  Google Scholar 

  3. Vasanthakumari R (2007) Autoimmunity. In Textbook of microbiology, BI Publications Pvt Ltd, New Delhi, p. 154–158

    Google Scholar 

  4. Green KJ, Simpson CL (2007) Desmosomes: new perspectives on a classic. J Invest Dermatol 127:2499–2515

    Article  PubMed  CAS  Google Scholar 

  5. Hatsell S, Cowin P (2001) Deconstructing desmoplakin. Nat Cell Biol 3:E270–272

    Article  PubMed  CAS  Google Scholar 

  6. Stanley JR (2008) Pemphigus. In: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ (eds) Fitzpatrick’s Dermatology in General Medicine, 7th edn. McGraw Hill, New York, pp 459–468

    Google Scholar 

  7. Tsuruta D, Hashimoto T, Hamill KJ, Jones JC (2011) Hemidesmosomes and focal contact proteins: functions and cross-talk in keratinocytes, bullous diseases and wound healing. J Dermatol Sci 62:1–7

    PubMed  CAS  Google Scholar 

  8. Sterk LM, Geuijen CA, Oomen LC, Calafat J, Janssen H, Sonnenberg A (2000) The tetraspan molecule CD151, a novel constituent of hemidesmosomes, associates with the integrin alpha6beta4 and may regulate the spatial organization of hemidesmosomes. J Cell Biol 149:969–982

    Article  PubMed  CAS  Google Scholar 

  9. Tsuruta D, Kobayashi H, Imanishi H, Sugawara K, Ishii M, Jones JC (2008) Laminin-332-integrin interaction: a target for cancer therapy? Curr Med Chem 15:1968–1975

    Article  PubMed  CAS  Google Scholar 

  10. Jones JC, Hopkinson SB, Goldfinger LE (1998) Structure and assembly of hemidesmosomes. Bioessays 20:488–494

    Article  PubMed  CAS  Google Scholar 

  11. Sitaru C, Zillikens D (2005) Mechanisms of blister induction by autoantibodies. Exp Dermatol 14:861–875

    Article  PubMed  CAS  Google Scholar 

  12. Hashimoto T (2003) Recent advances in the study of the pathophysiology of pemphigus. Arch Dermatol Res 295(Suppl 1):S2–11

    PubMed  CAS  Google Scholar 

  13. Huilgol SC, Black MM (1995) Management of the immunobullous disorders. II. Pemphigus. Clin Exp Dermatol 20:283–293

    Article  PubMed  CAS  Google Scholar 

  14. Zimmermann J, Bahmer F, Rose C, Zillikens D, Schmidt E (2010) Clinical and immunopathological spectrum of paraneoplastic pemphigus. J Dtsch Dermatol Ges 8:598–606

    PubMed  Google Scholar 

  15. Amagai M (1999) Autoimmunity against desmosomal cadherins in pemphigus. J Dermatol Sci 20:92–102

    Article  PubMed  CAS  Google Scholar 

  16. Payne AS, Hanakawa Y, Amagai M, Stanley JR (2004) Desmosomes and disease: pemphigus and bullous impetigo. Curr Opin Cell Biol 16:536–543

    Article  PubMed  CAS  Google Scholar 

  17. Barnes LM, Clark ML, Estes SA, Bongiovanni GL (1987) Pemphigus vulgaris involving the esophagus. A case report and review of the literature. Dig Dis Sci 32:655–659

    Article  PubMed  CAS  Google Scholar 

  18. Frohlich (1951) Pemphigus vulgaris of the lower lip, tongue and conjunctiva. Z Haut Geschlechtskr 11:xi

    PubMed  CAS  Google Scholar 

  19. Onuma K, Kanbour-Shakir A, Modery J, Kanbour A (2009) Pemphigus vulgaris of the vagina—its cytomorphologic features on liquid-based cytology and pitfalls: case report and cytological differential diagnosis. Diagn Cytopathol 37:832–835

    Article  PubMed  Google Scholar 

  20. Pohla-Gubo G, Hintner H (2011) Direct and indirect immunofluorescence for the diagnosis of bullous autoimmune diseases. Dermatol Clin 29:365–372

    Article  PubMed  CAS  Google Scholar 

  21. Ishii K, Amagai M, Hall RP, Hashimoto T, Takayanagi A, Gamou S, Shimizu N, Nishikawa T (1997) Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins. J Immunol 159:2010–2017

    PubMed  CAS  Google Scholar 

  22. Tateishi C, Tsuruta D, Nakanishi T, Uehara S, Kobayashi H, Ishii M, Hashimoto T (2010) Antidesmocollin-1 antibody-positive, antidesmoglein antibody-negative pemphigus herpetiformis. J Am Acad Dermatol 63:e8–10

    Article  PubMed  Google Scholar 

  23. Maciejowska E, Jablonska S, Chorzelski T (1987) Is pemphigus herpetiformis an entity? Int J Dermatol 26:571–577

    Article  PubMed  CAS  Google Scholar 

  24. Kozlowska A, Hashimoto T, Jarzabek-Chorzelska M, Amagai A, Nagata Y, Strasz Z, Jablonska S (2003) Pemphigus herpetiformis with IgA and IgG antibodies to desmoglein 1 and IgG antibodies to desmocollin 3. J Am Acad Dermatol 48:117–122

    Article  PubMed  CAS  Google Scholar 

  25. Tsuruta D, Ishii N, Hamada T, Ohyama B, Fukuda S, Koga H, Imamura K, Kobayashi H, Karashima T, Nakama T, Dainichi T, Hashimoto T (2011) IgA pemphigus. Clin Dermatol 29:437–442

    Article  PubMed  Google Scholar 

  26. Hashimoto T, Kiyokawa C, Mori O, Miyasato M, Chidgey MA, Garrod DR, Kobayashi Y, Komori K, Ishii K, Amagai M, Nishikawa T (1997) Human desmocollin 1 (Dsc1) is an autoantigen for the subcorneal pustular dermatosis type of IgA pemphigus. J Invest Dermatol 109:127–131

    Article  PubMed  CAS  Google Scholar 

  27. Niimi Y, Kawana S, Hashimoto T, Kusunoki T (2003) Paraneoplastic pemphigus associated with uterine carcinoma. J Am Acad Dermatol 48:S69–72

    Article  PubMed  Google Scholar 

  28. Frew JW, Murrell DF (2011) Paraneoplastic pemphigus (paraneoplastic autoimmune multiorgan syndrome): clinical presentations and pathogenesis. Dermatol Clin 29:419–425

    Article  PubMed  CAS  Google Scholar 

  29. Anhalt GJ (2004) Paraneoplastic pemphigus. J Investig Dermatol Symp Proc 9:29–33

    Article  PubMed  Google Scholar 

  30. Lee SE, Kim HR, Hashimoto T, Kim SC (2008) Paraneoplastic pemphigus developed shortly after resection of follicular dendritic cell sarcoma. Acta Derm Venereol 88:410–412

    Article  PubMed  CAS  Google Scholar 

  31. Niimi Y, Ohyama B, Di Zenzo G, Calabresi V, Hashimoto T, Kawana S (2010) Paraneoplastic pemphigus presenting as mild cutaneous features of pemphigus foliaceus and lichenoid stomatitis with antidesmoglein 1 antibodies. Dermatol Res Pract pii:931340

    Google Scholar 

  32. Kulthanan K, Chularojanamontri L, Tuchinda P, Sirikudta W, Pinkaew S (2011) Prevalence and clinical features of Thai patients with bullous pemphigoid. Asian Pac J Allergy Immunol 29:66–72

    PubMed  Google Scholar 

  33. Stanley JR (2008) Bullous pemphigoi. In: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ (eds) Fitzpatrick’s dermatology in general medicine, 7th edn. McGraw Hill, New York, pp 475–480

    Google Scholar 

  34. Ogawa H, Sakuma M, Morioka S, Kitamura K, Sasai Y, Imamura S, Inaba Y (1995) The incidence of internal malignancies in pempphigus and bullous pemphigoid in Japan. J Dermatol Sci 9:136–141

    Article  PubMed  CAS  Google Scholar 

  35. Ujiie H, Shibaki A, Nishie W, Shimizu H (2010) What’s new in bullous pemphigoid. J Dermatol 37:194–204

    Article  PubMed  CAS  Google Scholar 

  36. Liu Z, Giudice GJ, Swartz SJ, Fairley JA, Till GO, Troy JL, Diaz LA (1995) The role of complement in experimental bullous pemphigoid. J Clin Invest 95:1539–1544

    Article  PubMed  CAS  Google Scholar 

  37. Schmidt E, Della Torre R, Borradori L (2011) Clinical features and practical diagnosis of bullous pemphigoid. Dermatol Clin 29:427–438

    PubMed  CAS  Google Scholar 

  38. Barnadas MA, Gelpi C, Curell R, de Moragas JM, Alomar A (1999) Repeat direct immuno­fluorescence (DIF) test, using, 1 M NaCl treated skin, in the subepidermal autoimmune bullous diseases that contain IgG at the dermal epidermal junction. J Cutan Pathol 26:37–41

    Article  PubMed  CAS  Google Scholar 

  39. Kobayashi M, Amagai M, Kuroda-Kinoshita K, Hashimoto T, Shirakata Y, Hashimoto K, Nishikawa T (2002) BP180 ELISA using bacterial recombinant NC16a protein as a diagnostic and monitoring tool for bullous pemphigoid. J Dermatol Sci 30:224–232

    Article  PubMed  CAS  Google Scholar 

  40. Yoshida M, Hamada T, Amagai M, Hashimoto K, Uehara R, Yamaguchi K, Imamura K, Okamoto E, Yasumoto S, Hashimoto T (2006) Enzyme-linked immunosorbent assay using bacterial recombinant proteins of human BP230 as a diagnostic tool for bullous pemphigoid. J Dermatol Sci 41:21–30

    Article  PubMed  CAS  Google Scholar 

  41. Egan CA, Yancey KB (2000) The clinical and immunopathological manifestations of anti-epiligrin cicatricial pemphigoid, a recently defined subepithelial autoimmune blistering disease. Eur J Dermatol 10:585–589

    PubMed  CAS  Google Scholar 

  42. Groth S, Recke A, Vafia K, Ludwig RJ, Hashimoto T, Zillikens D, Schmidt E (2011) Development of a simple enzyme-linked immunosorbent assay for the detection of autoantibodies in anti-p200 pemphigoid. Br J Dermatol 164:76–82

    Article  PubMed  CAS  Google Scholar 

  43. Fleming TE, Korman NJ (2000) Cicatricial pemphigoid. J Am Acad Dermatol 43:571–591, quiz 591–574

    Article  PubMed  CAS  Google Scholar 

  44. Zillikens D (2002) BP180 as the common autoantigen in blistering diseases with different clinical phenotypes. Keio J Med 51:21–28

    Article  PubMed  Google Scholar 

  45. Dainichi T, Takeshita H, Moroi Y, Urabe K, Yoshida M, Hisamatsu Y, Komai A, Duan H, Koga T, Hashimoto T, Furue M (2005) Cicatricial pemphigoid with autoantibodies against the laminin 5 gamma 2 subunit. Eur J Dermatol 15:189–193

    PubMed  Google Scholar 

  46. Balding SD, Prost C, Diaz LA, Bernard P, Bedane C, Aberdam D, Giudice GJ (1996) Cicatricial pemphigoid autoantibodies react with multiple sites on the BP180 extracellular domain. J Invest Dermatol 106:141–146

    Article  PubMed  CAS  Google Scholar 

  47. Horvath B, Niedermeier A, Podstawa E, Muller R, Hunzelmann N, Karpati S, Hertl M (2010) IgA autoantibodies in the pemphigoids and linear IgA bullous dermatosis. Exp Dermatol 19:648–653

    Article  PubMed  CAS  Google Scholar 

  48. Kobayashi K, Tanaka M, Nakajima S, Ito H, Harada T, Hashimoto T (2009) Simultaneous occurrence of anti-BP180 mucous membrane pemphigoid and mucosal-dominant pemphigus vulgaris. Clin Exp Dermatol 34:e785–e788

    Article  PubMed  CAS  Google Scholar 

  49. Lazarova Z, Salato VK, Lanschuetzer CM, Janson M, Fairley JA, Yancey KB (2008) IgG anti-laminin-332 autoantibodies are present in a subset of patients with mucous membrane, but not bullous, pemphigoid. J Am Acad Dermatol 58:951–958

    Article  PubMed  Google Scholar 

  50. Bhol KC, Dans MJ, Simmons RK, Foster CS, Giancotti FG, Ahmed AR (2000) The autoantibodies to alpha 6 beta 4 integrin of patients affected by ocular cicatricial pemphigoid predominantly epitopes within the large cytoplasmic doman of human beta 4. J Immunol 165:2824–2829

    PubMed  CAS  Google Scholar 

  51. Dilling A, Rose C, Hashimoto T, Zillikens D, Shimanovich I (2007) Anti-p200 pemphigoid: a novel autoimmune subepidermal blistering disease. J Dermatol 34:1–8

    Article  PubMed  Google Scholar 

  52. Dainichi T, Kurono S, Ohyama B, Ishii N, Sanzen N, Hayashi M, Shimono C, Taniguchi Y, Koga H, Karashima T, Yasumoto S, Zillikens D, Sekiguchi K, Hashimoto T (2009) Anti-laminin gamma-1 pemphigoid. Proc Natl Acad Sci U S A 106:2800–2805

    Article  PubMed  CAS  Google Scholar 

  53. Halkier-Sorensen L, Beck HI, Sogaard H (1985) Herpes gestationis in association with neoplasma malignum generalisata. A case report. Acta Derm Venereol Suppl (Stockh) 120:96–100

    CAS  Google Scholar 

  54. Intong LR, Murrell DF (2011) Pemphigoid gestationis: pathogenesis and clinical features. Dermatol Clin 29:447–452

    Article  PubMed  CAS  Google Scholar 

  55. Murakami H, Amagai M, Higashiyama M, Hashimoto K, Chorzelski TP, Bhogal BS, Jenkins RE, Black MM, Zillikens D, Nishikawa T, Hashimoto T (1996) Analysis of antigens recognized by autoantibodies in herpes gestationis. Usefulness of immunoblotting using a fusion protein representing an extracellular domain of the 180 kD bullous pemphigoid antigen. J Dermatol Sci 13:112–117

    Article  PubMed  CAS  Google Scholar 

  56. Matsumura K, Amagai M, Nishikawa T, Hashimoto T (1996) The majority of bullous pemphigoid and herpes gestationis serum samples react with the NC16a domain of the 180-kDa bullous pemphigoid antigen. Arch Dermatol Res 288:507–509

    Article  PubMed  CAS  Google Scholar 

  57. Semkova K, Black M (2009) Pemphigoid gestationis: current insights into pathogenesis and treatment. Eur J Obstet Gynecol Reprod Biol 145:138–144

    Article  PubMed  Google Scholar 

  58. Al-Fouzan AW, Galadari I, Oumeish I, Oumeish OY (2006) Herpes gestationis (Pemphigoid gestationis). Clin Dermatol 24:109–112

    Article  PubMed  Google Scholar 

  59. Rose C, Brocker EB, Zillikens D (2010) Clinical, histological and immunpathological findings in 32 patients with dermatitis herpetiformis Duhring. J Dtsch Dermatol Ges 8:265–270, 265–271

    Article  PubMed  Google Scholar 

  60. Marks J, Shuster S, Watson AJ (1966) Small-bowel changes in dermatitis herpetiformis. Lancet 2:1280–1282

    Article  PubMed  CAS  Google Scholar 

  61. Zone JJ, Meyer LJ, Petersen MJ (1996) Deposition of granular IgA relative to clinical lesions in dermatitis herpetiformis. Arch Dermatol 132:912–918

    Article  PubMed  CAS  Google Scholar 

  62. Rose C, Armbruster FP, Ruppert J, Igl BW, Zillikens D, Shimanovich I (2009) Autoantibodies against epidermal transglutaminase are a sensitive diagnostic marker in patients with dermatitis herpetiformis on a normal or gluten-free diet. J Am Acad Dermatol 61:39–43

    Article  PubMed  CAS  Google Scholar 

  63. Asano Y, Makino T, Ishida W, Furuichi M, Shimizu T (2011) Detection of antibodies to epidermal transglutaminase but not tissue transglutaminase in Japanese patients with dermatitis herpetiformis. Br J Dermatol 164:883–884

    Article  PubMed  CAS  Google Scholar 

  64. Horiguchi Y, Ikoma A, Sakai R, Masatsugu A, Ohta M, Hashimoto T (2008) Linear IgA dermatosis: report of an infantile case and analysis of 213 cases in Japan. J Dermatol 35:737–743

    Article  PubMed  CAS  Google Scholar 

  65. Franzke CW, Bruckner-Tuderman L, Blobel CP (2009) Shedding of collagen XVII/BP180 in skin depends on both ADAM10 and ADAM9. J Biol Chem 284:23386–23396

    Article  PubMed  CAS  Google Scholar 

  66. Csorba K, Schmidt S, Florea F, Ishii N, Hashimoto T, Hertl M, Karpati S, Bruckner-Tuderman L, Nishie W, Sitaru C (2011) Development of an ELISA for sensitive and specific detection of IgA autoantibodies aganist BP180 in pemphigoid diseases. Orphanet J Rare Dis 6:31

    Article  PubMed  Google Scholar 

  67. Ishii N, Hamada T, Dainichi T, Karashima T, Nakama T, Yasumoto S, Zillikens D, Hashimoto T (2010) Epidermolysis bullosa acquisita: what’s new? J Dermatol 37:220–230

    Article  PubMed  Google Scholar 

  68. Cardones AR, Hall RP 3rd (2011) Pathophysiology of dermatitis herpetiformis: a model for cutaneous manifestations of gastrointestinal inflammation. Dermatol Clin 29:469–477

    PubMed  CAS  Google Scholar 

  69. Yanagihara S, Mizuno N, Naruse A, Tateishi C, Tsuruta D, Ishii M (2011) Linear immunoglobulin G/immunoglobulin A bullous dermatosis associated with Vogt-Koyanagi-Harada disease. J Dermatol 38:798–801

    Article  PubMed  Google Scholar 

  70. Murakami H, Nishioka S, Setterfield J, Bhogal BS, Black MM, Zillikens D, Yancey KB, Balding SD, Giudice GJ, Diaz LA, Nishikawa T, Kiyokawa C, Hashimoto T (1998) Analysis of antigens targeted by circulating IgG and IgA autoantibodies in 50 patients with cicatricial pemphigoid. J Dermatol Sci 17:39–44

    Article  PubMed  CAS  Google Scholar 

  71. Kharfi M, Khaled A, Karaa A, Zaraa I, Fazaa B, Kamoun MR (2010) Linear IgA bullous dermatosis: the more frequent bullous dermatosis of children. Dermatol Online J 16:2

    PubMed  Google Scholar 

  72. Challacombe SJ, Setterfield J, Shirlaw P, Harman K, Scully C, Black MM (2001) Immunodiagnosis of pemphigus and mucous membrane pemphigoid. Acta Odontol Scand 59:226–234

    Article  PubMed  CAS  Google Scholar 

  73. Yokouchi M, Saleh MA, Kuroda K, Hachiya T, Stanley JR, Amagai M, Ishii K (2009) Pathogenic epitopes of autoantibodies in pemphigus reside in the amino-terminal adhesive region of desmogleins which are unmasked by proteolytic processing of prosequence. J Invest Dermatol 129:2156–2166

    Article  PubMed  CAS  Google Scholar 

  74. Schmidt E, Zillikens D (2010) Modern diagnosis of autoimmune blistering skin diseases. Autoimmun Rev 10:84–89

    Article  PubMed  CAS  Google Scholar 

  75. Saleh MA, Ishii K, Kim YJ, Murakami A, Ishii N, Hashimoto T, Schmidt E, Zillikens D, Shirakata Y, Hashimoto K, Kitajima Y, Amagai M (2011) Development of NC1 and NC2 domains of Type VII collagen ELISA for the diagnosis and analysis of the time course of epidermolysis bullosa acquisita patients. J Dermatol Sci 62:169–175

    Article  PubMed  CAS  Google Scholar 

  76. Probst C, Schlumberger W, Stocker W, Recke A, Schmidt E, Hashimoto T, Zhu XJ, Zillikens D, Komorowski L (2009) Development of ELISA for the specific determination of autoantibodies against envoplakin and periplakin in paraneoplastic pemphigus. Clin Chim Acta 410:13–18

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

We greatly appreciate Ms. Ayumi Suzuki, Ms. Takako Ishikawa, and Ms. Sachiko Sakaguchi for technical assistance, and Ms. Akiko Tanaka, Ms. Yasuko Nakayama, Ms. Emiko Hara, Ms. Hanako Tomita, Ms. Mihoko Ikeda, Ms. Kyoko Akashi, and Ms. Nobuko Ishii for secretarial work.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Takashi Hashimoto .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Tsuruta, D., Dainichi, T., Hamada, T., Ishii, N., Hashimoto, T. (2013). Molecular Diagnosis of Autoimmune Blistering Diseases. In: Has, C., Sitaru, C. (eds) Molecular Dermatology. Methods in Molecular Biology, vol 961. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-227-8_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-62703-227-8_2

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-62703-226-1

  • Online ISBN: 978-1-62703-227-8

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics